Osivax picks up Series A funding
Osivax, a French developer of vaccines and immunotherapies, has secured 8 million euros in Series A financing. Noshaq led the round.
10 July 2019•1 min read
Osivax, a French developer of vaccines and immunotherapies, has secured 8 million euros in Series A financing. Noshaq led the round.
